KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Capital Leases (2016 - 2023)

Historic Capital Leases for Staar Surgical (STAA) over the last 14 years, with Q4 2023 value amounting to $42000.0.

  • Staar Surgical's Capital Leases fell 8000.0% to $42000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $42000.0, marking a year-over-year decrease of 8000.0%. This contributed to the annual value of $42000.0 for FY2023, which is 8000.0% down from last year.
  • As of Q4 2023, Staar Surgical's Capital Leases stood at $42000.0, which was down 8000.0% from $84000.0 recorded in Q3 2023.
  • Staar Surgical's 5-year Capital Leases high stood at $656000.0 for Q1 2019, and its period low was $21000.0 during Q4 2021.
  • Moreover, its 5-year median value for Capital Leases was $149500.0 (2020), whereas its average is $219650.0.
  • Per our database at Business Quant, Staar Surgical's Capital Leases crashed by 8961.75% in 2021 and then surged by 110714.29% in 2022.
  • Staar Surgical's Capital Leases (Quarter) stood at $471000.0 in 2019, then crashed by 84.5% to $73000.0 in 2020, then surged by 423.29% to $382000.0 in 2021, then crashed by 45.03% to $210000.0 in 2022, then plummeted by 80.0% to $42000.0 in 2023.
  • Its last three reported values are $42000.0 in Q4 2023, $84000.0 for Q3 2023, and $125000.0 during Q2 2023.